Literature DB >> 28516882

Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients.

Marco Sebastiani1, Andreina Manfredi2, Giulia Cassone2, Gilda Sandri2, Stefania Cerri3, Clodoveo Ferri2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28516882

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  6 in total

1.  Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.

Authors:  Maria Antonietta Barbieri; Giuseppe Cicala; Paola Maria Cutroneo; Elisabetta Gerratana; Caterina Palleria; Caterina De Sarro; Ada Vero; Luigi Iannone; Antonia Manti; Emilio Russo; Giovambattista De Sarro; Fabiola Atzeni; Edoardo Spina
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

Review 2.  Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.

Authors:  Giulia Cassone; Marco Sebastiani; Caterina Vacchi; Gian Luca Erre; Carlo Salvarani; Andreina Manfredi
Journal:  Drugs Context       Date:  2021-01-15

3.  Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.

Authors:  Caterina Vacchi; Andreina Manfredi; Giulia Cassone; Stefania Cerri; Giovanni Della Casa; Dario Andrisani; Carlo Salvarani; Marco Sebastiani
Journal:  Case Rep Med       Date:  2021-04-22

4.  Personalized Medicine and Machine Learning: A Roadmap for the Future.

Authors:  Marco Sebastiani; Caterina Vacchi; Andreina Manfredi; Giulia Cassone
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

Review 5.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

6.  Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.

Authors:  Giulia Cassone; Andreina Manfredi; Fabiola Atzeni; Vincenzo Venerito; Caterina Vacchi; Valentina Picerno; Federica Furini; Gian Luca Erre; Paola Tomietto; Anna Laura Fedele; Giovanni Della Casa; Valeria Nucera; Chiara Giannitti; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.